The widely-used antacid medication, Digene Gel, manufactured in Goa, is facing scrutiny and a recall after several complaints were lodged regarding its quality and efficacy. India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued an advisory to halt the sale and distribution of this product, raising concerns about potential health risks to consumers.
Digene Gel, produced by the pharmaceutical company based in Goa, is a popular over-the-counter antacid used to relieve symptoms of heartburn, acidity, and indigestion. However, reports of ineffectiveness and adverse reactions from some users have prompted the CDSCO to take action.
The CDSCO’s advisory recommends that all distributors, pharmacies, and retailers immediately cease the sale and distribution of Digene Gel manufactured in Goa. Consumers who have purchased the product have been advised to discontinue its use and return it to the point of purchase for a refund or replacement.
While the CDSCO has not disclosed specific details about the complaints or the nature of the issues with the product, it has initiated an investigation into the matter. The drug regulator has also ordered the manufacturer to recall the affected batches of Digene Gel and conduct a thorough assessment of the product’s quality and safety.
Health authorities are reminding consumers to exercise caution when using over-the-counter medications and to report any adverse reactions or concerns about product quality to the appropriate regulatory authorities.
The recall of Digene Gel underscores the importance of stringent quality control and monitoring in the pharmaceutical industry to ensure the safety and efficacy of medical products. As the investigation progresses, more information will be made available regarding the specific issues with the product and any necessary actions to rectify the situation.
Consumers are encouraged to stay informed about product recalls and advisories issued by regulatory authorities to protect their health and well-being when using over-the-counter medications and healthcare products.
Author: IBC Global Times
Discover a whole new perspective with our channel, where comprehensive analysis and fearless reporting take center stage. Experience journalism that goes beyond the noise and clutter, offering clarity and depth. Unlock the power to inform, interpret, challenge, and provoke as a subscriber of our channel. With unlimited access to our journalism, you'll have the ability to explore unique viewpoints, delve into thought-provoking content, and stay ahead of the curve. Subscribe now to gain exclusive access to our channel and join a community of individuals who value insightful reporting. Don't miss out on the opportunity to expand your knowledge and engage with journalism that truly makes a difference. Subscribe today and embark on a journey of discovery with our channel.
